⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 5 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 5 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT August 27, 2026

Bexsero Injektionssuspension in Fertigspritze Impfstoff gegen Meningokokken der Gruppe B (rDNA, Komponenten, adsorbiert) (Injektionssuspension)

📷 EU Safety Watch placeholder
Bexsero Injektionssuspension in Fertigspritze Impfstoff gegen Meningokokken der Gruppe B (rDNA, Komponenten, adsorbiert) (Injektionssuspension)
📷 EU Safety Watch placeholder
Bexsero injection suspension in pre-filled syringe is a vaccine against meningococcal group B disease (rDNA, component, adsorbed) (injection suspension). Parallel export is banned due to limited production capacity.
⚠️
Shortage ongoing
NEISSERIA MENINGITIDIS (AUSZUG is currently in short supply in AT.
📈 Timeline
13 days active so far
August 29, 2026 September 10, 2026

What is this? This is a vaccine called Bexsero. It helps protect against a serious infection called meningococcal group B.

What's happening? There is not enough of this vaccine right now. The company cannot make enough to meet demand.

Does this affect me? If you need this vaccine in Austria, you may have trouble getting it.

What should I do? Ask your doctor or pharmacist if another vaccine is right for you.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Agency-published detail

🚫 Parallel export ban active · ATC: J07AH09 · Reason: Kapazitätsengpässe bei der Herstellung · Marketing authorisation holder: Glaxosmithkline Vaccines S.r.l., Via Fiorentina 1, 53100 Siena, Italien · Affected packs: 1 Stück Schachtel, Fertigspritze [eingeschränkt verfügbar, since 2026-08-27, resupply 2026-12-31]

First published
August 27, 2026
Last refreshed by us
17 hours ago
Severity (as classified)
Medium
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

Low AT resolved 3 weeks ago

Alluzience 200 Speywood-Einheiten/ml Injektionslösung 200 U/ml (Injektionslösung)

Alluzience 200 Speywood units/ml injection solution 200 U/ml (injection solution) Reason: Increased additional demand Marketing authorisation holder: Ipsen Pharma, 70 Rue Balard, 75015 Paris, French...
Medium AT resolved 2 months ago

Boostrix Injektionssuspension in einer Fertigspritze (Injektionssuspension in einer Fertigspritze)

Parallel export ban in effect.
Medium AT resolved 4 months ago

Trumenba Injektionssuspension in einer Fertigspritze, Meningokokken-Gruppe B-Impfstoff (rekombinant, adsorbiert) (Injektionssuspension)

Trumenba injection suspension in a pre-filled syringe, meningococcal group B vaccine (recombinant, adsorbed) (injection suspension)
Medium AT resolved 10 months ago

Shingrix Pulver und Suspension zur Herstellung einer Injektionssuspension, Herpes-Zoster-Impfstoff (rekombinant, adjuvantiert) (Pulver und Suspension zur Herstellung einer Injektionssuspension)

Shingrix powder and suspension for preparing an injectable suspension, herpes zoster vaccine (recombinant, adjuvanted) (powder and suspension for preparing an injectable suspension) Parallel export i...

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Bexsero Injektionssuspension in Fertigspritze Impfstoff gegen Meningokokken der Gruppe B (rDNA, Komponenten, adsorbiert) (Injektionssuspension). Bexsero injection suspension in pre-filled syringe is a vaccine against meningococcal group B disease (rDNA, component, adsorbed) (injection suspension). Parallel export is banned due to limited production capacity.
▸ When was this alert issued?
This alert was issued on August 27, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Medium risk. A medium risk means harm is possible under certain conditions. Read the notice and act on the recommended steps.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.